CASI 주가 차트
CASI 주가 예측
CASI Pharmaceuticals Inc
$0
0%
$0
종가: Jun 18, 16:00:00 GMT-4
$0
0%
$0
애프터마켓: Jun 18, 20:00:00 GMT-4
뒤로
CASI Pharmaceuticals Inc (CASI) 주가 예측
주요 통계
이전 종가
--
시가
--
일일 범위
-
52주 범위
-
거래량
--
평균 거래량
--
배당수익률
--
EPS(TTM)
--
시가총액
--
CASI란 무엇인가요?
CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing innovative therapeutics and pharmaceutical products. The company is headquartered in Beijing, Beijing and currently employs 233 full-time employees. The company went IPO on 2021-08-23. The Company’s main business is engaged in acquiring, developing and commercializing products that augment its hematology oncology, autoimmune and organ transplant rejection therapeutic area focus as well as other unmet medical need. The Company’s main products include EVOMELA (Melphalan for Injection), FOLOTYN (Pralatrexate), CNCT19, BI-1206, CB-5339, CID-103, Thiotepa and others. The firm mainly conducts its business in the domestic market.
